Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Austria

Research and Innovation Action · Running

PERIFORMANCE Public Engagement in Research Infrastructures for Mission Cancer: Managing Complexity of Emerging Technologies

Coordinator
Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric), Austria
Runs
1 September 2025 to 31 August 2028
Status
Running
EU funding
€2.4m
Total cost
€2.4m
Partners
13 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101216808

What the project is doing

In the project's own words, from its summary on CORDIS.

Enhancing stakeholder engagement in cancer research is essential for advancing the relevance, impact, ethicality, and equity of research outcomes. Engaging patients, caregivers, clinicians, researchers, and community representatives in the research process enables synergistic optimisation of potential impact. The PERIFORMANCE project focuses on promoting local action for Mission: Cancer and aims to leverage the federated biobanking domain as focal points for transdisciplinary research and innovation activities with European outreach.

Biobanks, particularly those using population cohorts dedicated to cancer research, set the sampling frame to explore best practices and identify needs in the context of stakeholder engagement. PERIFORMANCE goes beyond the standard patient/public involvement (PPI) practices and adopts a quadruple helix perspective on stakeholders, which includes patients and donors, research and healthcare professionals, industry partners, and policymakers.

By addressing the use of AI and EHDS in biobanking within cancer research, the project aligns with the call’s objectives to foster systemic solutions at a time of major sociotechnical transformations. Its emphasis on ethical, legal, and societal dimensions resonates with the call’s focus on ensuring that technological advancements contribute positively to public trust and societal well-being. PERIFORMANCE prioritises broad dissemination and training, ensuring its outcomes are widely accessible and scalable.

Its approach supports the call’s goal of achieving broad, lasting impact across Europe, reinforced by an open call for bottom-up engagement exercises in diverse contexts, considering local or regional needs. PERIFORMANCE will contribute to the EU’s Mission: Cancer by fostering informed participation among stakeholders, enhancing the ethical use of new technologies and boosting the relevance and equity in public policy and research outcomes.

Who is involved

OrganisationCityCountryRole
Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric)GrazAustriaCoordinator
Universitat WienWienAustriaParticipant
Cancer Patients EuropeBruxelles / BrusselBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Tartu UlikoolTartuEstoniaParticipant
Elliniki Omospondia Karkinou Ell OkAthinaGreeceParticipant
Elliniko Diktyo Frontiston EpioniAthensGreeceParticipant
Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos IiiMadridSpainParticipant
Centre International De Recherche Sur Le CancerLyon 7emeFranceParticipant
Eurordis - Rare Diseases EuropeParisFranceParticipant
Latvijas UniversitateRigaLatviaParticipant
Universita Ta MaltaMsidaMaltaParticipant
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek ZiekenhuisAmsterdamNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI